Cryogenic catheter probe, system, and method for selective ablation of mucosa and submucosa of the gastrointestinal tract
Disclosed is a cryogenic catheter probe, cryogenic ablation system, and use thereof for performing cryogenic ablation of mucosal tissue and/or of both mucosal tissue and submucosal tissue in the gastrointestinal tract of a subject. The cryogenic catheter probe includes a chamber and a channel assembly housed within the chamber. The channel assembly includes a central rail, at least one cryogenic fluid delivery channel, a delivery channel guide, and a sprayer guide. The at least one cryogenic fluid delivery channel has a fluid delivery channel portion and a sprayer connected to the fluid delivery channel portion, and is mounted on the central rail for longitudinal movement along the central rail. The sprayer is configured to release cryogenic spray in at least one treatment zone along the hollow body portion of the chamber.
1 . A cryogenic catheter probe comprising:
a chamber comprising a distal end, a proximal end, and a hollow body portion disposed between the distal and proximal ends, wherein said distal end is adapted for connection with a distal probe tip, and wherein said proximal end is adapted for connection with a shaft; and
a channel assembly housed within the chamber, said channel assembly comprising:
(i) a central rail;
(ii) at least one cryogenic fluid delivery channel comprising a fluid delivery channel portion and a sprayer connected to the distal end of the fluid delivery channel portion, said at least one cryogenic fluid delivery channel being mounted on the central rail for longitudinal movement along the central rail;
(iii) a delivery channel guide for guiding the at least one cryogenic fluid delivery channel longitudinally along the central rail during operation of the probe; and
(iv) a sprayer guide for guiding the sprayer of the at least one cryogenic fluid delivery channel longitudinally along the central rail during operation of the probe, the sprayer guide comprising a central opening configured to fit around the central rail and an exterior or interior groove for the sprayer of at least one cryogenic fluid delivery channel to be guided thereby,
wherein said sprayer is configured to release cryogenic spray in at least one treatment zone along the hollow body portion of the chamber.
2 . The probe according to claim 1 , further comprising a distal probe tip attached to the distal end of the probe.
3 . The probe according to claim 1 , wherein the delivery channel guide comprises a central opening configured to fit around the central rail and an exterior or interior groove of the at least one cryogenic fluid delivery channel to be guided thereby.
4 . The probe according to claim 1 , wherein the central opening of the sprayer guide is configured so that it prevents rotation of the sprayer guide around the central opening.
5 . The probe according to claim 1 , wherein the channel assembly comprises 1 to 20 cryogenic fluid delivery channels.
6 . The probe according to claim 1 , wherein the channel assembly comprises a number of cryogenic fluid delivery channels selected from the group consisting of 1, 2, 3, 4, 5, 6, 7, and 8 cryogenic fluid delivery channels.
7 . The probe according to claim 1 , wherein the number of interior or exterior grooves of the sprayer guide are the same as the number of cryogenic fluid delivery channels.
8 . The probe according to claim 1 , wherein the at least one cryogenic fluid delivery channel comprises at least two cryogenic fluid delivery channels, and wherein the sprayers of each of the cryogenic fluid delivery channels are configured to release cryogenic spray either in unison or independently of one another.
9 . The probe according to claim 1 , wherein the at least one cryogenic fluid delivery channel comprises at least two cryogenic fluid delivery channels, and wherein each sprayer is configured to release cryogenic spray in a different treatment zone along the probe.
10 . The probe according to claim 1 , wherein said catheter is configured for selective ablation in the mucosa and submucosa of a gastrointestinal tract of a subject.
11 . The probe according to claim 1 , wherein the at least one cryogenic fluid delivery channel comprises at least two cryogenic fluid delivery channels, wherein the cryogenic fluid delivery channels are independently controlled and turned to an on or off position.
12 . The probe according to claim 1 , wherein the treatment tissue comprises mucosal and/or submucosal tissue of the large intestine, small intestine, stomach, esophagus, rectum, and anus.
13 . A cryogenic ablation system comprising:
a cryogenic catheter probe according to claim 1 ;
a catheter portion functionally connected to the probe; and
a controller configured to control the functionality of the cryogenic catheter probe.
14 . A method of performing cryogenic ablation of mucosal tissue and/or of both mucosal tissue and submucosal tissue in the gastrointestinal tract of a subject, said method comprising:
(a) providing a cryogenic ablation system according to claim 13 ;
(b) contacting the cryogenic catheter probe of the system with a target treatment region of the gastrointestinal tract of the subject; and
(c) releasing a cryogenic fluid from the at least one sprayer to treat the target treatment region by cryogenically ablating at least a portion the mucosal tissue or ablating at least a portion of both the mucosal and submucosal tissue of the target treatment region.
15 . The method according to claim 14 , wherein the target treatment region comprises mucosal tissue and/or both mucosal and submucosal tissue of the large intestine, small intestine, stomach, esophagus, rectum, or anus of the subject.
16 . The method according to claim 15 , wherein treating the target treatment region comprises performing a series of tissue ablation steps, each comprising ablation of an axial length of the large intestine, small intestine, stomach, esophagus, rectum, or anus of the subject, wherein each ablation step is optionally preceded by a tissue expansion step.
17 . A method for performing a medical procedure in a small intestine and/or stomach of a patient in need of said medical procedure, the method comprising:
(a) providing a cryogenic ablation system according to claim 13 ;
(b) contacting the cryogenic catheter probe of the system with a target treatment region of the small intestine and/or stomach of the patient; and
(c) releasing a cryogenic fluid from the at least one sprayer to treat the target treatment region by cryogenically ablating at least a portion the mucosal tissue or ablating at least a portion of both the mucosal and submucosal tissue of the target treatment region,
thereby performing a medical procedure to treat a condition of the patient selected from the group consisting of Type 1 diabetes, Type 2 diabetes, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and obesity.